Optimizing Platelet Isolation (The Cell Study)
NCT04470505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2025-10-17
Summary
The research study is about blood cells (platelets) and their power houses (mitochondria). The investigators want to learn about their behavior in order to ensure that our laboratory procedures are generating optimal results.
Conditions
- Healthy
Sponsors & Collaborators
-
Arkansas Children's Hospital Research Institute
lead OTHER
Eligibility
- Min Age
- 25 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-07-06
- Primary Completion
- 2021-01-25
- Completion
- 2021-01-25
Countries
- United States
Study Locations
More Related Trials
-
A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)
NCT01054443 ·Status: TERMINATED ·Phase: PHASE2
-
Thrombosomes® in Bleeding Thrombocytopenic Patients
NCT03394755 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies
NCT05935202 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Constitutional Platelet Disease
NCT04419987 ·Status: UNKNOWN ·Phase: NA
-
A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence
NCT03194542 ·Status: COMPLETED ·Phase: PHASE2
-
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
NCT05820126 ·Status: RECRUITING ·Phase: PHASE2
-
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
NCT05654766 ·Status: UNKNOWN
-
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
NCT06792019 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
NCT05217719 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study
NCT02653443 ·Status: TERMINATED ·Phase: PHASE2
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING
-
Study on the Safety and Efficacy of Cryopreserved Platelets in Hypoproliferative Thrombocytopenic Patients
NCT05067608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease
NCT05823376 ·Status: RECRUITING
-
A Trial of Hetrombopag in Healthy Subjects
NCT05088174 ·Status: COMPLETED ·Phase: PHASE1
-
Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery
NCT06673498 ·Status: RECRUITING ·Phase: PHASE2
-
A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects
NCT05088642 ·Status: COMPLETED ·Phase: PHASE1
-
An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)
NCT05223920 ·Status: COMPLETED ·Phase: PHASE2
-
Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)
NCT06287567 ·Status: COMPLETED ·Phase: PHASE2
-
The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
NCT06507436 ·Status: RECRUITING ·Phase: PHASE3
-
Platelet Function With Various Storage Techniques
NCT03338660 ·Status: WITHDRAWN ·Phase: PHASE2
-
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)
NCT04272970 ·Status: COMPLETED ·Phase: NA
-
Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers
NCT00432770 ·Status: COMPLETED ·Phase: PHASE1
-
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
NCT06824727 ·Status: COMPLETED
-
Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months
NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis
NCT01149681 ·Status: COMPLETED ·Phase: PHASE2